Investing in the Future of Precision Cancer Medicine

Developing a first-in-class, 3rd generation Polo-like Kinase 1 (PLK1) Inhibitor to treat leukemias, lymphomas
and solid tumor cancers

Marcum 2017 MicroCap Conference
June 15, 2017
12:00pm - 12:30pm PDT

Bill Welch, CEO of Trovagene, will be presenting at the Marcum 2017 MicroCap Conference on June 15, 2017 at 3:00 PM EDT at the Grand Hyatt Hotel in Julliard on the conference level. The presentation will be webcast live at http://wsw.com/webcast/marcum5/trov and can also be accessed through the Trovagene website at www.trovagene.investorroom.com.  A replay of the presentation will be available and archived for 90 days